Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/ESSA PHARMA INC/ DEFA14A

SEC Filing · DEFA14A

ESSA PHARMA INC

SEC Filing

Filed Sep 30, 2025Accepted Sep 30, 2025, 12:30 PM EDTCIK 1633932Accession 0001104659-25-095060
View company →Permanent SEC source ↗
Share

Company context

ESSA is a pharmaceutical company that was previously focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com.

Historical securities (1)
EPIXNASDAQ · EQUITY · Historical · closed Oct 8, 2025

Recent company filings

  1. EFFECT filingNov 14, 2025
  2. SCHEDULE 13G/A - filed by TANG CAPITAL MANAGEMENT LLC regarding ESSA Pharma Inc.Nov 14, 2025
  3. SCHEDULE 13G/A - filed by TANG CAPITAL MANAGEMENT LLC regarding ESSA Pharma Inc.Nov 14, 2025
  4. 15-12G filingOct 28, 2025
  5. 4 filingOct 15, 2025

As-filed source

Primary evidence
As filedOpen full document ↗